Literature DB >> 17710666

Non-alcoholic fatty liver disease.

Einar Björnsson1, Paul Angulo.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17710666     DOI： 10.1080/00365520701514529

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN： 0036-5521            Impact factor:   2.423


× No keyword cloud information.
  15 in total

1.  Evaluation of Nonalcoholic Fatty Liver Disease in C57BL/6J Mice by Using MRI and Histopathologic Analyses.

Authors:  Jae-Eun Ryu; Woori Jo; Hyun-Ji Choi; Sungwoong Jang; Hyo-Ju Lee; Dong-Cheul Woo; Jeong Kon Kim; Kyung Won Kim; Eun Sil Yu; Woo-Chan Son
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

2.  Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.

Authors:  Dao-Yu Tan; Hai-Yan Shi; Chang-Ping Li; Xiao-Ling Zhong; Ming Kang
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

Review 3.  Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations.

Authors:  Zaki A Sherif; Armana Saeed; Shima Ghavimi; Seyed-Mehdi Nouraie; Adeyinka O Laiyemo; Hassan Brim; Hassan Ashktorab
Journal:  Dig Dis Sci       Date:  2016-04-01       Impact factor: 3.199

4.  High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model.

Authors:  Michael Nathan VanSaun; In Kyu Lee; Mary Kay Washington; Lynn Matrisian; David Lee Gorden
Journal:  Am J Pathol       Date:  2009-06-18       Impact factor: 4.307

5.  Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidences.

Authors:  Roya Kelishadi; Sanam Farajian; Maryam Mirlohi
Journal:  Hepat Mon       Date:  2013-04-09       Impact factor: 0.660

6.  Increased Serum Levels of LIGHT/TNFSF14 in Nonalcoholic Fatty Liver Disease: Possible Role in Hepatic Inflammation.

Authors:  Kari Otterdal; John Willy Haukeland; Arne Yndestad; Tuva B Dahl; Sverre Holm; Filip M Segers; Ivar P Gladhaug; Zbigniew Konopski; Jan Kristian Damås; Bente Halvorsen; Pål Aukrust
Journal:  Clin Transl Gastroenterol       Date:  2015-07-02       Impact factor: 4.488

7.  Prediction and Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD) and Identification of Its Associated Factors Using the Classification Tree Method.

Authors:  Mehdi Birjandi; Seyyed Mohammad Taghi Ayatollahi; Saeedeh Pourahmad; Ali Reza Safarpour
Journal:  Iran Red Crescent Med J       Date:  2016-08-09       Impact factor: 0.611

8.  Effects of rosuvastatin and/or β-carotene on non-alcoholic fatty liver in rats.

Authors:  Sayed H Seif El-Din; Naglaa M El-Lakkany; Abeer A El-Naggar; Olfat A Hammam; Hekma A Abd El-Latif; Afaf A Ain-Shoka; Fatma A Ebeid
Journal:  Res Pharm Sci       Date:  2015 Jul-Aug

9.  Protective effect of Sam-Hwang-Sa-Sim-Tang against hepatic steatosis in mice fed a high-cholesterol diet.

Authors:  Tae-Gue Ahn; Joo-Young Lee; Se-Yun Cheon; Hyo-Jin An; Yoon-Bum Kook
Journal:  BMC Complement Altern Med       Date:  2013-12-23       Impact factor: 3.659

10.  In Situ Evaluation of Oxidative Stress in Rat Fatty Liver Induced by a Methionine- and Choline-Deficient Diet.

Authors:  Isabel Freitas; Eleonora Boncompagni; Eleonora Tarantola; Cristian Gruppi; Vittorio Bertone; Andrea Ferrigno; Gloria Milanesi; Rita Vaccarone; M Enrica Tira; Mariapia Vairetti
Journal:  Oxid Med Cell Longev       Date:  2016-01-06       Impact factor: 6.543
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.